Cytokinetics (NASDAQ:CYTK) EVP Sells $112,590.76 in Stock

Cytokinetics (NASDAQ:CYTK) EVP Sells $112,590.76 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,798 shares of the firm's stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $62.62, for a total value of $112,590.76. Following the transaction, the executive vice president directly owned 50,440 shares in the company, valued at $3,158,552.80. This trade represents a 3.44% decrease in their ownership of the stock. The sa…